News: GTC Biotherapeutics, Inc. (GTCB.O)

GTCB.O on Consolidated Issue listed on NASDAQ Capital Market

0.63USD
18 Dec 2009
Price Change (% chg)

$-0.11 (-14.86%)
Prev Close
$0.74
Open
$0.71
Day's High
$0.73
Day's Low
$0.63
Volume
77,679
Avg. Vol
25,925
52-wk High
$9.50
52-wk Low
$0.65

view news for:
Select another date:

Wed, May 6 2009

Lundbeck launches drug from DNA-altered goats

* Danish company launches anti-clotting drug ATryn in U.S.

Continue Reading

U.S. approves first drug from DNA-altered animals

WASHINGTON (Reuters) - U.S. health officials on Friday approved the first drug made using genetically engineered animals despite lingering concerns over health and environmental implications.

UPDATE 3-U.S. approves first drug from DNA-altered animals

WASHINGTON, Feb 6 (Reuters) - U.S. health officials on Friday approved the first drug made using genetically engineered animals despite lingering concerns over health and environmental implications.

U.S. approves first drug from DNA-altered animals

WASHINGTON (Reuters) - U.S. health officials on Friday approved the first drug made using genetically engineered animals, amid lingering concerns about genetic implications.

US FDA approves GTC's animal-based drug Atryn

WASHINGTON, Feb 6 (Reuters) - The U.S. Food and Drug Administration has approved GTC Biotherapeutics Inc's experimental anticlotting therapy called Atryn, a spokesman for the company said on Friday.

U.S. advisers back 1st drug from DNA-altered animals

ROCKVILLE, Maryland (Reuters) - The first drug made using genetically engineered animals to near U.S. approval won key support on Friday from an advisory panel that judged it safe and effective despite concerns from groups worried about the genetic tinkering.

U.S. advisers back 1st drug from DNA-altered animals

ROCKVILLE, Maryland (Reuters) - The first drug made using genetically engineered animals to near U.S. approval won key support on Friday from an advisory panel that judged it safe and effective despite concerns from groups worried about the genetic tinkering.

UPDATE 2-US advisers back 1st drug from DNA-altered animals

(Recasts first paragraph, adds FDA and company comments, detail on the drug)

U.S. panel backs first drug from DNA-altered animals

ROCKVILLE, Maryland (Reuters) - A U.S. advisory panel recommended approval of what would be the first drug made using genetically engineered animals on the U.S. market, saying it appeared safe and effective despite concerns heard from groups worried about the genetic tinkering.

UPDATE 1-US panel backs first drug from DNA-altered animals

ROCKVILLE, Md., Jan 9 (Reuters) - A U.S. advisory panel recommended approval of what would be the first drug made using genetically engineered animals on the U.S. market, saying it appeared safe and effective despite concerns heard from groups worried about the genetic tinkering.

Select another date:

Market Views

Press Releases

view news for: